The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.
J Hum Hypertens
; 29(5): 316-23, 2015 May.
Article
in En
| MEDLINE
| ID: mdl-25273857
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fumarates
/
Amides
/
Hypertension
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Hum Hypertens
Journal subject:
ANGIOLOGIA
Year:
2015
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Reino Unido